This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
US Marijuana Industry to Flourish in 2019: Who Gains?
by Nalak Das
Legalization has long been considered a boon for the marijuana industry.
Options Traders Expect Huge Moves in Cronos (CRON) Stock
by Zacks Equity Research
Investors need to pay close attention to Cronos (CRON) stock based on the movements in the options market lately.
Cronos Group (CRON) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cronos Group (CRON) closed at $21.48 in the latest trading session, marking a -0.97% move from the prior day.
Altria (MO) Hurt by Low Cigarette Sales, Inclines Toward RRPs
by Zacks Equity Research
Altria (MO) is undertaking efforts to expand in the RRPs space amid receding cigarette shipping volumes.
Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Cronos Group (CRON) closed at $21.14, marking a -1.08% move from the previous day.
Altria Focuses on RRPs Growth, Closes Investment in Cronos
by Zacks Equity Research
Altria (MO) closes investment deal in Cronos Group. The move is in sync with the company's efforts to expand in the smokeless category.
Cronos (CRON) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on regular top and bottom-line numbers along with pipeline progress when Cronos (CRON) reports fourth-quarter results.
What Investors Need to Know About Investing in Marijuana Stocks
by Benjamin Rains
Let's look at what investors need to know about the marijuana industry and how to invest in the future of pot.
ETFs and Stocks to Tap the Marijuana Boom
by Sweta Killa
First it was bitcoin that made investors go on a mad rush, and today, it's marijuana. Now that legalization is steadily gaining traction across the U.S., more investors than ever before are looking for ways to cash in.
4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019
by Sanghamitra Saha
Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.
Why Marijuana ETFs are on a High in 2019
by Sweta Killa
After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets. Here's why ETFs are riding high this year.
4 Best Marijuana Stocks to Play the Green Rush
by Zacks Equity Research
Whether its eating a gooey, chocolatey brownie or taking a few hits off a freshly rolled joint, it???s common knowledge that a lot of people like to get high. Many investors, however, have yet to "light up." What are the best marijuana stocks out there right now?
Pot Stocks: Who Has the Best Earnings Chart?
by Tracey Ryniec
Pot stocks are entering the investing mainstream but do they have what it takes to compete against mature industries?
Will Q4 Results Continue to Fuel Momentum in Marijuana ETF?
by Sweta Killa
Investors are keenly watching whether legalization is living up to the hype in the quarterly results of the cannabis stocks.
Buy the Dip in Marijuana Stocks & ETF?
by Sanghamitra Saha
Marijuana stocks and ETF slumped on Feb 6. Is this the time to buy?
Marijuana ETF Joins Billion Dollar Club
by Sweta Killa
Marijuana ETF has now accumulated billion dollars in AUM since its inception in less than 14 months.
Pot Stocks are on a High: Play These Marijuana ETFs
by Sanghamitra Saha
As marijuana stocks soar into the new year, which ETFs should investors consider?
The Zacks Analyst Blog Highlights: Cronos, Altria, Canopy and Tilray
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cronos, Altria, Canopy and Tilray
Here's Why Cannabis Stocks (ACB, CRON) Are Gaining Today
by Ryan McQueeney
Shares of several notable cannabis stocks, including Aurora Cannabis (ACB) and Cronos Group (CRON), were up more than 10% through early afternoon trading hours Monday.
5 Top Performing Stocks of Marijuana ETF
by Sweta Killa
We have highlighted five best-performing stocks of the top ETF of January.
Altria (MO) Q4 Earnings Beat, Strong Pricing Aids Revenues
by Zacks Equity Research
Altria's (MO) Q4 performance gains on improved pricing. However, shipment volume in the smokeable unit continued to decline.
Cronos Group (CRON) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cronos Group (CRON) closed the most recent trading day at $18.15, moving -1.79% from the previous trading session.
What Makes Marijuana ETF the Best Performer in January?
by Sanghamitra Saha
These are the factors that led marijuana ETF to see a strong start to 2019.
Altria's (MO) Q4 Earnings to Gain From Prudent Pricing & RRPs
by Zacks Equity Research
Altria (MO) gains from higher pricing as well as rising popularity of low risk tobacco products. However, declining cigarette sales volumes is a worry.
Cronos Group (CRON) Catches Eye: Stock Jumps 9.1%
by Zacks Equity Research
Cronos Group (CRON) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.